We are live on
!
Find out more
SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
2 hedge funds and large institutions have $1K invested in Sophiris Bio, Inc. in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 2 → 2 (0)
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
SPHS Hedge Fund Activity: Q3 2021 in Review
2 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2021, worth a combined $1K.
Fund positioning in SPHS was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 2 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $1K of Sophiris Bio, Inc. stock for Q3 2021.
- 0 funds opened new Sophiris Bio, Inc. positions in Q3 2021 and 0 closed out.
Based on aggregated 13F filings for Q3 2021.